Table 3.
Sudomotor abnormalities for individual patients at initial and final assessment
| Patient | Sudomotor abnormalitiesa
|
|||||
|---|---|---|---|---|---|---|
| Initial assessment | 1st follow-up | 2nd follow-up | 3rd follow-up | 4th follow-up | 5th follow-up | |
| 1 | Post-ganglionic | Post-ganglionic | ||||
| 2 | Post-ganglionic | Post-ganglionic | Post-ganglionic | Post-ganglionic | Post-ganglionic | |
| 3 | Post-ganglionic | Post-ganglionic | ||||
| 4 | Post-ganglionic | Post-ganglionic | Post-ganglionic | Post-ganglionic | Post-ganglionic | Post-ganglionic |
| 5 | Post-ganglionic | Post-ganglionic | ||||
| 6 | Preganglionic | Normal | ||||
| 7 | Preganglionic | Post-ganglionic | Post-ganglionic | |||
| 8 | Post-ganglionic | Post-ganglionic | Post-ganglionic | Post-ganglionic | Post-ganglionic | |
| 9 | Preganglionic | Mixed | Normal | |||
a
Sudomotor abnormalities are designated as pre- or post-ganglionic. Please refer to “Methods”. Time between the initial and final assessments is the same as that listed in Table 2